Atea Pharmaceuticals, Inc. business relationships
Companies named in Atea Pharmaceuticals, Inc.’s 10-K filed 2026-03-05, and public companies whose annual reports name Atea Pharmaceuticals, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.7 / 10
- AI naming
- 13 / 100 Top 2% in its category
- Agent readiness
- 5 / 100
- AI adoption
- 0 / 100
Named in Atea Pharmaceuticals, Inc.’s annual report 3
“In that circumstance, we would need to obtain a license from Gilead Sciences, which may not be available on reasonable terms, if at all.” SEC filing
“Merck has the right to terminate the Merck License Agreement immediately if we commence any interference or opposition proceeding or other challenge to the validity or enforceability of any Merck patent licensed to us under the Merck License Agreement or if we otherwise oppose any extension of, or t...” SEC filing
“We have exclusively licensed three patent families from Merck covering composition of matter, process of preparation, and formulations of ruzasvir, a pan-genotypic NS5A inhibitor which we are combining with” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.